Latest Security News

Cardiex Limited has successfully raised $2.4 million through an institutional placement to boost manufacturing and commercial activities for its CONNEQT Pulse device.

Empire Energy Group has launched a $28 million equity raise to finance critical development activities in the Beetaloo Basin, targeting first gas sales from its Carpentaria Pilot Project in 2025. The capital raise, combined with a $65 million financing package, underpins the company’s ambition to commercialize one of Australia’s largest low-CO2 shale gas resources.

Challenger Gold Limited has had its trading suspension lifted immediately following its announcement on capital raising activities, signaling renewed market activity.

Challenger Gold Limited’s Preliminary Feasibility Study for the Hualilan Toll Milling Project outlines a robust three-year operation delivering 450,000 tonnes of gold-silver ore to Austral Gold’s Casposo plant, with strong economics and low upfront capital.

Challenger Gold has completed a Pre-Feasibility Study for toll milling at its Hualilan Gold Project, revealing strong economics, low capital requirements, and a swift payback period. The study underscores the project's potential to generate significant cash flow over three years through a toll milling arrangement with Austral Gold.

Challenger Gold has raised A$34.5 million through an institutional placement to fund near-term gold production and expand development at its Hualilan project in Argentina.

Battery Age Minerals Ltd (ASX, BM8) has responded to an ASX price query following a notable jump in its share price and trading volume, attributing the activity to recent public communications and exploration progress.

Focus Minerals has completed the sale of its Laverton Gold Project to Genesis Minerals for A$250 million in cash, marking a significant shift in its asset portfolio. The company now turns its attention to optimising operations at its Coolgardie Gold Project.

Anagenics Limited’s proprietary hair regrowth technology powers the newly launched Bouf Haircare brand, which has achieved over $500,000 in sales in its first week, setting the stage for a lucrative royalty stream.

Nyrada has secured ethics approval to amend its Phase I clinical trial protocol for Xolatryp, allowing testing of higher doses and extended infusion times. This strategic move aims to refine dosing ahead of Phase II trials, with final Phase I results expected by September 2025.

Elph Investments has raised and finalised its off-market takeover bid for Engenco Limited shares at $0.31 per share, applying to all shareholders including those who already accepted. This move signals a decisive step in the ongoing acquisition process.

QuickFee Limited reports mixed Q4 FY25 results with solid growth in US Pay Now and Australian Finance, offset by a significant US Finance decline due to credit impairment. The company completes a major refinancing and capital raise while maintaining FY25 earnings guidance.